Activation of the acquired immune response reduces coupled bone formation in response to a periodontal pathogen.
Osteoimmunolgy involves the interaction of the immune system with skeletal elements. This interaction can lead to the formation of osseous lesions. To investigate how the acquired immune response could contribute to osteolytic lesions, we injected the periodontal pathogen Porphyromonas gingivalis adjacent to calvarial bone with or without prior immunization against the bacterium. Activation of the acquired immune response increased osteoclastogenesis and decreased coupled bone formation. The latter was accompanied by an increase in nuclear translocation of the transcription factor FOXO1 in vivo, increased apoptosis of bone-lining cells measured by the TUNEL assay and number of activated caspase-3 positive cells and a decrease in bone lining cell density. Further studies were conducted with MC3T3 osteoblastic cells. Apoptosis and increased FOXO1 DNA binding activity were induced when a combination of cytokines was tested, IL-beta, TNF-alpha, and IFN-gamma. Knockdown of FOXO1 by small interfering RNA significantly reduced cytokine stimulated apoptosis, cleaved caspase-3/7 activity and decreased mRNA levels of the proapoptotic genes, TNF-alpha, FADD, and caspase-3, -8, and -9. These results indicate that activation of the acquired immunity by a periodontal pathogen reduces the coupling of bone formation and resorption. This may occur by enhancing bone lining cell apoptosis through a mechanism that involves increased FOXO1 activation. These studies give insight into inflammatory bone diseases such as periodontal disease and arthritis were the formation of lytic lesions occurs in conjunction with deficient bone formation and activation of an acquired immune response.
Behl
Yugal
Y
Department of Periodontology and Oral Biology, Boston University School of Dental Medicine, Boston, MA 02118, USA.
Siqueira
Michelle
M
Ortiz
Javier
J
Li
Jingchao
J
Desta
Tesfahun
T
Faibish
Dan
D
Graves
Dana T
DT
D016475:3T3 Cells; D000818:Animals; D017209:Apoptosis / Q000276:immunology; D016866:Bacteroidaceae Infections / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D001862:Bone Resorption / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D000071161:Forkhead Box Protein O1; D051858:Forkhead Transcription Factors / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D007110:Immunity, Active / Q000235:genetics; D051379:Mice; D010006:Osteoblasts / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D010014:Osteolysis / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology*; D010518:Periodontitis / Q000276:immunology* / Q000382:microbiology* / Q000473:pathology; D010521:Periosteum / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D016966:Porphyromonas gingivalis / Q000276:immunology*; D034741:RNA, Small Interfering / Q000235:genetics
D000071161:Forkhead Box Protein O1; D051858:Forkhead Transcription Factors; C467200:Foxo1 protein, mouse; D034741:RNA, Small Interfering